The first reactive arthritis case associated with COVID-19.
Reads0
Chats0
TLDR
The first reactive artrhritis associated with COVID-19 infection is reported, a 73-year-old man with diabetes mellitus, hypertension and coronary heart disease, who presented to emergency department with a history of fever, weakness, and dry cough for one week.Abstract:
Novel coronavirus disease 2019 (COVID-19) arised from Wuhan Province in China in December 2019, has quickly become a global public health emergency. The first confirmed COVID-19 patient in Turkey was reported on 11th March 2020. A 73-year-old man with diabetes mellitus, hypertension and coronary heart disease presented to emergency department with a history of fever, weakness, and dry cough for one week. Nasopharyngeal and oropharyngeal swabs were positive for COVID-19. He was treated with ceftriaxone, hidroxychloroquine and azitromycin Severeal days after completion of COVID-19 treatment, asymetric oligoarticular arthritis in his lower extremities were developed. In the course of time, clinicians all over the world experienced several different forms of COVID-19. In this case, we report the first reactive artrhritis associated with COVID-19 infection. This article is protected by copyright. All rights reserved.read more
Citations
More filters
Journal ArticleDOI
The intersection of COVID-19 and autoimmunity.
Jason S. Knight,Roberto Caricchio,Jean-Laurent Casanova,Alexis J. Combes,Betty Diamond,Sharon E. Fox,David A. Hanauer,Judith A. James,Yogendra Kanthi,Virginia Ladd,Puja Mehta,Aaron M. Ring,Ignacio Sanz,Carlo Selmi,Russell P. Tracy,Paul J. Utz,Catriona A. Wagner,Julia Y. Wang,W. Joseph McCune +18 more
TL;DR: The potential role of auto-immunity in post-acute sequelae of COVID-19 pneumonia was discussed in this paper, highlighting the current understanding, evolving concepts, and unanswered questions provided by this unique opportunity to determine mechanisms by which a viral infection can be exacerbated by, and even trigger, auto-IMM.
Journal ArticleDOI
COVID-19 and the clinical course of rheumatic manifestations.
TL;DR: The manifestations of COVID-19 have been evolving over time as discussed by the authors, and various post-COVID19 syndromes are being recognised, including reactive arthritis and connective tissue disorders such as lupus and inflammatory myositis.
Journal ArticleDOI
Post-COVID-19 arthritis: a case report and literature review.
TL;DR: In this paper, a case of acute oligoarthritis occurring 13 days after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) severe pneumonia in a middle-aged Caucasian man was described.
Journal ArticleDOI
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
TL;DR: There are 2 faces of the immune response against SARS-CoV-2, that include a benign virus controlling immune response and a many faceted range of dysregulated multi-tissue and organ directed autoimmune responses that provides a major challenge in the management of this viral disease.
Journal ArticleDOI
Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.
TL;DR: In this paper, a systematic review indicated the potential of the coronavirus disease 2019 to trigger a myriad of autoimmune and rheumatic manifestations, which should be considered amid global efforts to combat COVID-19.
References
More filters
Journal ArticleDOI
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
Mahmoud Gheblawi,Kaiming Wang,Anissa Viveiros,Quynh Nguyen,Jiu Chang Zhong,Anthony J. Turner,Mohan K. Raizada,Maria B. Grant,Gavin Y. Oudit +8 more
TL;DR: A review summarizes the progress over the past 20 years, highlighting the critical role of ACE2 as the novel SARS-CoV-2 receptor and as the negative regulator of the renin-angiotensin system, together with implications for the coronavirus disease 2019 pandemic and associated cardiovascular diseases.
Journal ArticleDOI
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Wen Zhang,Yan Zhao,Fengchun Zhang,Qian Wang,Tai-sheng Li,Zhengyin Liu,Jinglan Wang,Yan Qin,Xuan Zhang,Xiaowei Yan,Xiaofeng Zeng,Shuyang Zhang +11 more
TL;DR: The clinical and immunological characteristics of severe patients, and the current evidence and share the experience in anti-inflammation treatment of patients with severe COVID-19 that may have an impaired immune system are discussed.
Journal ArticleDOI
Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Sravanthi Parasa,Madhav Desai,Viveksandeep Thoguluva Chandrasekar,Harsh K. Patel,Kevin F. Kennedy,Thomas Roesch,Marco Spadaccini,Matteo Colombo,Roberto Gabbiadini,Everson L.A. Artifon,Alessandro Repici,Prateek Sharma +11 more
TL;DR: It is suggested that patients with SARS-CoV-2 infection can present with gastrointestinal symptoms with possible fecal-oral route of transmission due to the presence of viral RNA in stool.
Journal ArticleDOI
Immunomodulation in COVID-19.
Nicholas E. Ingraham,Sahar Lotfi-Emran,Beth K Thielen,Kristina Techar,Rachel Morris,Shernan G. Holtan,R. Adams Dudley,Christopher J. Tignanelli +7 more
TL;DR: A systematic review and meta-analysis of randomized clinical trials found that PD-1 inhibitor-related pneumonitis in advanced cancer patients: Radiographic patterns and clinical course may be related to duration of infection.
Journal ArticleDOI
Pathogenesis of ankylosing spondylitis and reactive arthritis.
TL;DR: Recent advances provide additional new insights into distinct pathogenetic mechanisms in AS and ReA that arise from a complex interplay between genetic factors including HLA-B27 and environmental factors.